Decreased plasma cholesterol esterification and cholesteryl ester transfer in hypopituitary patients on glucocorticoid replacement therapy

REFERENCES

• RoseÂn T, Bengtsson BAÊ . Premature mortality due to cardiovascular disease in hypopituitarism. Lancet 1990; 336: 285 ± 8.
   Google Scholar
• Bates AS, Van't Hoff W, Jones PJ, Clayton RN. The effect of hypopituitarism on life expectancy. J Clin Endocrinol Metab 1996; 81: 1169 ± 72.
   Google Scholar
• BuÈlow B, Hagmar L, Mikoczy Z, NordstroÈm CH, Erfurth EM. Increased cerebrovascular mortality in patients with hypopituitarism. Clin Endocrinol 1997; 46: 75 ± 81.
   Google Scholar
• Markussis V, Beshyah SA, Fisher C, Sharp P, Nicolaides AN, Johnston DG. Detection of premature atherosclerosis by high-resolution ultrasonography in symptom-free hypopituitary adults. Lancet 1992; 340: 1188 ± 92.
   PubMedGoogle Scholar
• RoseÂn T, Eden S, Larson G, Wilhelmsen L, Bengtsson BAÊ . Cardiovascular risk factors in adult patients with growth hormone de®ciency. Acta Endocrinol 1993; 129: 195 ± 200.
   Google Scholar
• Carroll PV, Christ ER, Bengtsson BAÊ, Carlsson L, Christiansen JS, Clemmons D, et al. Growth hormone de®ciency in adulthood and the effects of growth hormone replacement: a review. Growth Hormone Research Society Scienti®c Committee. J Clin Endocrinol Metab 1998; 83: 382 ± 95.
   Google Scholar
• Al-Shoumer KAS, Cox KH, Hughes CL, Richmond W, Johnston DG. Fasting and postprandial lipid abnormalities in hypopituitary women receiving conventional replacement therapy. J Clin Endocrinol Metab 1997; 82: 2653 ± 9.
   Google Scholar
• RoseÂn T, Wilhelmsen L, Bengtsson BAÊ . Altered lipid pattern explains increased cardiovascular mortality in hypopituitary patients with growth hormone de®ciency. Clin Endocrinol 1998; 48: 525 ± 6.
   Google Scholar
• Esteban NV, Loughlin T, Yergey AL, Zawadzki JK, Booth JD, Winterer JC, et al. Daily cortisol production rate in man determined by stable isotope dilution/mass spectrometry. J Clin Endocrinol Metab 1991; 72: 39 ± 45.
   PubMedGoogle Scholar
• Kraan GP, Dullaart RPF, Pratt JJ, Wolthers BG, Drayer NM, De Bruin R. The daily cortisol production reinvestigated in healthy men. The serum and urinary cortisol production rates are not signi®cantly different. J Clin Endocrinol Metab 1998; 83: 1247 ± 52.
   Google Scholar
• DeVile CJ, Stanhope R. Hydrocortisone replacement therapy in children and adolescents with hypopituitarism. Clin Endocrinol 1997; 47: 37 ± 41. 12 Kissebah AH. `Stress' hormones and lipid metabolism. Proc R Soc Med 1974; 67: 665 ± 7.
   Google Scholar
• Luton JP, Richard C, Laudat MH, Pinon JC, Bricaire H. Cardiovascular diseases and lipid abnormalities in Cushing's syndrome. Nouv Presse Med 1982; 11: 2693 ± 8.
   Google Scholar
• Stone NJ. Secondary causes of hyperlipedemia. Med Clin North Am 1994; 78: 117 ± 41. 15 Andrews RC, Walker BR. Glucocorticoids and insulin resistance. Old hormones, new targets. Clin Sci 1999; 96: 513 ± 23.
   Google Scholar
• Jauhiainen M, Metso J, Pahlman R, Blomqvist S, Van Tol A, Ehnholm C. Human plasma phospholipid transfer protein causes high density lipoprotein conversion. J Biol Chem 1993; 268: 4032 ± 6.
   PubMedGoogle Scholar
• Tu AY, Nishida HI, Nishida T. High density lipoprotein conversion mediated by human plasma phospholipid transfer protein. J Biol Chem 1993; 268: 23098 ± 105.
   Google Scholar
• Castro GR, Fielding CJ. Early incorporation of cell-derived cholesterol into pre-beta-migrating high-density lipoprotein. Biochemistry 1988; 27: 25 ± 9.
   PubMedGoogle Scholar
• Von Eckardstein A, Jauhiainen M, Huang Y, Metso J, Langer C, Pussinen P, et al. Phospholipid transfer protein mediated conversion of high density lipoproteins generates pre beta 1-HDL. Biochim Biophys Acta 1996; 1301: 255 ± 62.
   PubMedGoogle Scholar
• Eisenberg S. High density lipoprotein metabolism. J Lipid Res 1984; 25: 1017 ± 58.
   PubMedGoogle Scholar
• Dullaart RPF, Groener JEM, Erkelens DW. Cholesterylester transfer between lipoproteins. Diab Nutr Metab 1991; 4: 329 ± 43.
   Google Scholar
• Tall AR. Plasma cholesteryl ester transfer protein. J Lipid Res 1993; 34: 1255 ± 74.
   PubMedGoogle Scholar
• Fielding CJ, Fielding PE. Molecular physiology of reverse cholesterol transport. J Lipid Res 1995; 36: 211 ± 28.
   PubMedGoogle Scholar
• Bruce C, Tall AR. Cholesteryl ester transfer proteins, reverse cholesterol transport, and atherosclerosis. Curr Opin Lipidol 1995; 6: 306 ± 11.
   PubMedGoogle Scholar
• Barter PJ, Rye KA. Molecular mechanisms of reverse cholesterol transport. Curr Opin Lipidol 1996; 7: 82 ± 7.
   PubMedGoogle Scholar
• Beentjes JAM, Tjeerdsma G, Sluiter WJ, Dullaart RPF. Divergence between growth hormone responses to insulin-induced hypoglycaemia and growth hormone-releasing hormone in patients with non-functioning pituitary macroadenomas and hyperprolactinaemia. Clin Endocrinol 1996; 45: 391 ± 8.
   PubMedGoogle Scholar
• Toogood AA, Beardwell CG, Shalet SM. The severity of growth hormone de®ciency in adults with pituitary disease is related to the degree of hypopituitarism. Clin Endocrinol 1994; 41: 511 ± 6.
   Google Scholar
• Lukaski HC, Johnson PE, Bolonchuk WW, Lykken GI. Assessment of fat-free mass using bioelectrical impedance measurements of the human body. Am J Clin Nutr 1985; 41: 810 ± 7.
   PubMedGoogle Scholar
• Matthews DR, Hosker JP, Rudenski AS, Naylor BA, Treacher DF, Turner RC. Homeostasis model assessment: insulin resistance and b-cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia 1985; 28: 412 ± 9.
   PubMedGoogle Scholar
• Demacker PN, Hijmans AG, Vos-Janssen HE, Van't Laar A, Jansen AP. A study of the use of polyethylene glycol in estimating cholesterol in high-density lipoprotein. Clin Chem 1980; 26: 1775 ± 9.
   Google Scholar
• Dullaart RPF, Sluiter WJ, Dikkeschei LD, Hoogenberg K, Van Tol A. Effect of adiposity on plasma lipid transfer protein activities: a possible link between insulin resistance and high density lipoprotein metabolism. Eur J Clin Invest 1994; 24: 188 ± 94.
   Google Scholar
• Groener JEM, Pelton RW, Kostner GM. Improved estimation of cholesteryl ester transfer/ exchange activity in serum or plasma. Clin Chem 1986; 32: 283 ± 6.
   Google Scholar
• Floren CH, Chen CH, Franzen J, Albers JJ. Lecithin: cholesterol acyltransferase in liver disease. Scand J Clin Lab Invest 1987; 47: 613 ± 7.
   PubMedGoogle Scholar
• Hannuksela M, Marcel YL, Kesaniemi YA, Savolainen MJ. Reduction in the concentration and activity of plasma cholesteryl ester transfer protein by alcohol. J Lipid Res 1992; 33: 737 ± 44.
   PubMedGoogle Scholar
• Speijer H, Groener JEM, Van Ramshorst E, Van Tol A. Different locations of cholesteryl ester transfer protein and phospholipid transfer protein activities in plasma. Atherosclerosis 1991; 90: 159 ± 68. 36 Channon KM, Clegg RJ, Bhatnagar D, Ishola M, Arrol S, Durrington PN. Investigation of lipid transfer in human serum leading to the development of an isotopic method for the determination of endogenous cholesterol esteri®cation and transfer. Atherosclerosis 1990; 80: 217 ± 26.
   Google Scholar
• Dullaart RPF, Riemens SC, Scheek LM, Van Tol A. Insulin decreases plasma cholesterylester transfer but not cholesterol esteri®cation in healthy subjects as well as in normotriglyceridaemic patients with type 2 diabetes. Eur J Clin Invest 1999; 29: 663 ± 71.
   Google Scholar
• Sutherland WH, Walker RJ, Lewis-Barned NJ, Pratt H, Tillman HC. Plasma cholesteryl ester transfer in patients with non-insulin dependent diabetes mellitus. Clin Chim Acta 1994; 231: 29 ±
   Google Scholar
• Wolthers BG, De Vries IJ, Volmer M, Nagel GT. Detection of 3 beta-hydroxysteroid dehydrogenase de®ciency in a newborn by means of urinary steroid analysis. Clin Chim Acta 1987; 169: 109 ± 16.
   PubMedGoogle Scholar
• Zumoff B, Fukushima DK, Hellman L. Intercomparison of four methods for measuring cortisol production. J Clin Endocrinol Metab 1974; 38: 169 ± 75.
   Google Scholar
• Palermo M, Shackleton CH, Mantero F, Stewart PM. Urinary free cortisone and the assessment of 11 beta-hydroxysteroid dehydrogenase activity in man. Clin Endocrinol 1996; 45: 605 ± 11.
   PubMedGoogle Scholar
• Jover E, Paradinas C, Prieto J, Arranz MT, Para J, Velasco R. Study of the effect of ACTH and cortisol on the plasms lipids in man using thinlayer chromatography. J Med 1976; 7: 131 ± 42.
   PubMedGoogle Scholar
• Jansen H, Van Tol A, Auwerx J, Skretting G, Staels B. Opposite regulation of hepatic lipase and lecithin: cholesterol acyltransferase by glucocorticoids in rats. Biochim Biophys Acta 1992; 1128: 181 ± 5.
   PubMedGoogle Scholar
• Riemens SC, Van Tol A, Stulp BK, Dullaart RPF. In¯uence of insulin sensitivity and the TaqIB cholesteryl ester transfer protein gene polymorphism on plasma lecithin:cholesterol acyltransferase and lipid transfer protein activities and their response to hyperinsulinemia in non-diabetic men. J Lipid Res 1999; 40: 1467 ± 74.
   PubMedGoogle Scholar
• Radeau T, Robb M, Lau P, Borthwick J, McPherson R. Relationship of adipose tissue cholesteryl ester transfer protein (CETP) mRNA to plasma concentrations of CETP in man. Atherosclerosis 1998; 139: 369 ± 76.
   Google Scholar
• Tall AR, Granot E, Brocia R, Tabas I, Hesler CB, Williams K, et al. Accelerated transfer of cholesteryl esters in dyslipidemic plasma. Role of cholesteryl ester transfer protein. J Clin Invest 1987; 79: 1217 ± 25.
   Google Scholar
• Mann CJ, Yen FT, Grant AM, Bihain BE. Mechanism of plasma cholesteryl ester transfer in hypertriglyceridemia. J Clin Invest 1991; 88: 2059 ± 66.
   PubMedGoogle Scholar
• Riemens SC, Van Tol A, Sluiter WJ, Dullaart RPF. Elevated plasma cholesteryl ester transfer in NIDDM: relationships with apolipoprotein Bcontaining lipoproteins and phospholipid transfer protein. Atherosclerosis 1998; 140: 71 ± 9.
   PubMedGoogle Scholar
• Taskinen MR, NikkilaÈ EA, Pelkonen R, Sane T. Plasma lipoproteins, lipolytic enzymes, and very low density lipoprotein triglyceride turnover in Cushing's syndrome. J Clin Endocrinol Metab 1983; 57: 619 ± 26.
   PubMedGoogle Scholar
• Hoeg JM, Santamarina-Fojo S, BeÂrard AM, Cornhill JF, Herderick EE, Feldman SH, et al. Overexpression of lecithin:cholesterol acyltransferase in transgenic rabbits prevents diet-induced atherosclerosis. Proc Natl Acad Sci USA 1996; 93: 11448 ± 53.
   PubMedGoogle Scholar
• Zhong S, Sharp DS, Grove JS, Bruce C, Yano K, Curb JD, et al. Increased coronary heart disease in Japanese ± American men with mutation in the cholesteryl ester transfer protein gene despite increased HDL levels. J Clin Invest 1996; 97: 2917 ± 23.
   PubMedGoogle Scholar
• Tall AR. Plasma lipid transfer proteins. J Lipid Res 1986; 27: 361 ± 7. 53 Fielding CJ, Havel RJ. Cholesteryl ester transfer protein: friend or foe? J Clin Invest 1996; 97: 2687 ± 8.
   Google Scholar